MatchaDB

2009期刊论文

Matcha, a powdered green tea, ameliorates the progression of renal and hepatic damage in type 2 diabetic OLETF rats.

Yamabe N, Kang KS, Hur JM, Yokozawa T

Journal of medicinal food

在出版方阅读→PubMed

摘要

Matcha, a powdered green tea produced by grinding with a stone mill, has been popularly used in the traditional tea ceremony and foods in Japan. Matcha is well known to be richer in some nutritional elements and epigallocatechin 3-O-gallate than other green teas. In our previous study, epigallocatechin 3-O-gallate exhibited protective effects against renal damage in a rat model of diabetic nephropathy. In the present study, we investigated the preventive effects of Matcha (50, 100, or 200 mg/kg/day) on the progression of hepatic and renal damage in type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. OLETF rats were orally administered Matcha for 16 weeks, and we assessed biochemical parameters in the serum, liver, and kidney and expression levels of major products of advanced glycation end products (AGEs), N(6)-(carboxylmethyl)lysine (CML) and N(6)-(carboxylethyl)lysine (CEL), receptor for AGE (RAGE), and sterol regulatory element binding proteins (SREBPs)-1 and -2. Serum total protein levels were significantly increased by Matcha administration, whereas the serum albumin and glycosylated protein levels as well as the renal glucose and triglyceride levels were only slightly or not at all affected. However, Matcha treatment significantly lowered the glucose, triglyceride, and total cholesterol levels in the serum and liver, renal AGE levels, and the serum thiobarbituric acid-reactive substances levels. In addition, Matcha supplementation resulted in decreases in the renal CML, CEL, and RAGE expressions as well as an increase in hepatic SREBP-2 expression, but not that of SREBP-1. These results suggest that Matcha protects against hepatic and renal damage through the suppression of renal AGE accumulation, by decreases in hepatic glucose, triglyceride, and…

摘要已缩短。在来源处阅读完整摘要。

摘要文本来自PubMed、OpenAlex或Europe PMC,版权归作者和出版方所有。

研究类型

动物研究

在小鼠、大鼠、鱼或其他动物身上进行的实验。

根据标题、摘要和主题词自动分配。

主题

抹茶是这里的主要研究对象(出现在标题中)。

关键词与主题词

你的研究文件夹

引用这项研究

Yamabe N, Kang KS, Hur JM, Yokozawa T. (2009). Matcha, a powdered green tea, ameliorates the progression of renal and hepatic damage in type 2 diabetic OLETF rats. Journal of medicinal food. https://doi.org/10.1089/jmf.2008.1282

DOI:10.1089/jmf.2008.1282 · PubMed ID:19735169 · 被引用39次(OpenAlex)

更多关于认知、情绪与压力

2020期刊论文可免费阅读

Health Benefits and Chemical Composition of Matcha Green Tea: A Review.

Kochman J, Jakubczyk K, Antoniewicz J等 — Molecules (Basel, Switzerland)

Japanese matcha is a type of powdered green tea, grown in a traditional way. Shading of the plants during the growth period enhances the processes of synthesis and accumulation of biologically active compounds, including theanine,…

综述认知、情绪与压力抗氧化物与多酚L-茶氨酸与咖啡因被引用376次
2018期刊论文可免费阅读

Stress-Reducing Function of Matcha Green Tea in Animal Experiments and Clinical Trials.

Unno K, Furushima D, Hamamoto S等 — Nutrients

Theanine, a major amino acid in green tea, exhibits a stress-reducing effect in mice and humans. Matcha, which is essentially theanine-rich powdered green tea, is abundant in caffeine. Caffeine has a strong antagonistic effect against…

随机对照试验认知、情绪与压力抗氧化物与多酚L-茶氨酸与咖啡因被引用98次
2017期刊论文可免费阅读

An intervention study on the effect of matcha tea, in drink and snack bar formats, on mood and cognitive performance.

Dietz C, Dekker M, Piqueras-Fiszman B — Food research international (Ottawa, Ont.)

Matcha tea is gaining popularity throughout the world in recent years and is frequently referred to as a mood-and-brain food. Previous research has demonstrated that three constituents present in matcha tea, l-theanine, epigallocatechin…

随机对照试验认知、情绪与压力抗氧化物与多酚L-茶氨酸与咖啡因被引用72次

浏览整个研究库→